期刊文献+

白内障超声乳化手术中联合玻璃体腔注射曲安奈德治疗糖尿病黄斑水肿合并重度白内障的疗效观察 被引量:24

Phacoemulsification with intravitreal triamcinolone injection to treat diabetic macular edema with severe cataract
原文传递
导出
摘要 目的 观察白内障超声乳化手术中联合玻璃体腔注射曲安奈德(IVTA)治疗糖尿病黄斑水肿(DME)合并重度白内障的临床效果。方法 临床检查确诊为DME伴重度白内障患者21例25只眼纳入研究。其中,15只眼行标准白内障超声乳化联合人工晶状体植入手术及IVTA治疗(IVTA组),10只眼仅行标准白内障超声乳化联合人工晶状体植入手术(非IVTA组)。所有患眼均行最佳矫正视力(BCVA)、裂隙灯显微镜、间接检眼镜及光相干断层扫描(OCT)检查。采用重复测量方差分析,对比IVTA组、非IVTA组手术后1、3、6个月的平均最小分辨角对数(logMAR)BCVA及黄斑中心凹厚度(CMT)变化情况。对手术前后logMAR BCVA与CMT行Pearson相关性分析。采用多元线性回归分析法分析影响手术后6个月视力恢复的相关因素。结果 重复测量方差分析结果显示,IVTA组与非IVTA组手术后平均logMAR BCVA均较手术前提高。IVTA组与非IVTA组手术前后平均logMAR BCVA比较,差异有统计学意义(F=4.855、6.235,P=0.037、0.020)。手术后1、3、6个月,IVTA组与非IVTA组平均logMAR BCVA改善程度比较,差异均无统计学意义(F=0.007、0.006、0.023,P=0.973、0.938、0.882)。手术后1、3个月,IVTA组CMT降低程度优于非IVTA组;两组CMT降低程度比较,差异有统计学意义(F=10.449、7.374,P=0.012、0.026)。手术后6个月,IVTA组与非IVTA组CMT降低程度比较,差异无统计学意义(F=2.173,P=0.114)。相关性分析结果显示,手术前及手术后6个月平均logMAR BCVA与平均CMT之间均无相关性(r=0.279、0.172,P=0.295、0.574)。多元线性回归分析结果显示,影响手术后6个月视力恢复的因素有外界膜状态和糖尿病病程(β=0.577、-0.411,P=0.025、0.030)。结论 白内障超声乳化手术中联合IVTA治疗DME合并重度白内障可在短期内减轻黄斑水肿,改善患者视力。 Objective To observe the efficacy of phacoemulsification with intravitreal triamcinolone injection (IVTA) in diabetic patients with severe cataract and diabetic macular edema (DME). Methods Twenty-one patients (25 eyes) with severe cataract and DME were enrolled in this retrospective study. Fifteen eyes underwent standard phacoemulsification and intraocular lens implantation with 4 mg IVTA at completion of surgery. Ten eyes underwent standard phacoemulsification and intraocular lens implantation. All the patients were followed up for best corrected visual acuity (BCVA), optical coherence tomography(OCT) and ophthalmological examination.Changes in logarithm of he minimal angel of resolution (logMAR) BCVA and central macular thickness (CMT) were evaluated preoperatively and 1 month, 3 months and 6 months postoperatively by repeated measures ANOVA. Correlations between logMAR BCVA and CMT preoperatively and postoperatively were analyzed by Pearson correlation analysis. Postoperative 6 months logMAR BCVA and affecting factors were evaluated by multivariate linear regression analysis. Results Both groups showed significant improvements of logMAR BCVA after surgery (F=4.855, 6.235;P=0.037, 0.020). There were no statistical differences of logMAR BCVA improvement at different time points postoperatively (F=0.007, 0.006, 0.023;P=0.973, 0.938, 0.882). The CMT reductions in IVTA group at month 1 and month 3 postoperatively were statistically significant than the reductions in group without IVTA(F=10.449, 7.374;P=0.012, 0.026), and there was no statistical difference of CMT reduction at month 6 postoperatively between two groups(F=2.173;P=0.114). Correlation Coefficients between CMT and BCVA were not statistically significant preoperatively and 6 months postoperatively(r=0.279, 0.172;P=0.295, 0.574). Analysis of multiple linear regression showed that external limiting membrane status and duration of diabetes are factors affecting the visual recovery (β=0.577,-0.411;P=0.025, 0.030). Conclusions Phacoemulsification with concurrent IVTA for treatment of patients with severe cataract and DME is effective in reducing edema. But IVTA does not further improve logMAR BCVA postoperatively.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2014年第2期141-144,共4页 Chinese Journal of Ocular Fundus Diseases
关键词 糖尿病视网膜病变 并发症 黄斑水肿 药物疗法 曲安奈德 治疗应用 Diabetic retinopathy/complications Macular edema/drug therapy Triamcinolone acetonide/therapeutic use
  • 相关文献

参考文献12

  • 1沈胤忱,许迅.糖尿病黄斑水肿的治疗现状[J].中华眼底病杂志,2013,29(1):108-111. 被引量:19
  • 2Zhang Y, Ma J, Meng N, et al. Comparison of intravitreal triamcinolone acetonide with intravitreal bevacizumab for treatment of diabetic maeular edema: a meta-analysis [J]. Curr Eye Res, 2013,38:578-587.
  • 3Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1 [J]. Arch Ophthalmol, 1985,103:1796-1806.
  • 4Group TWCG. A simplified cataract grading system [J]. Ophthalmic Epidemiol, 2002,9 : 83-95.
  • 5Ito S, Miyamoto N, Ishida K, et al. Association between external limiting membrane status and visual acuity in diabetic macular oedema [J]. Br J Ophthalmol, 2013,97228-232.
  • 6Lain DS, Chan CK, Mohamed S, et al. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema., a 6-month prospective pilot study [J]. Eye (Lond), 2005,19:885-890.
  • 7Yilmaz T, Weaver CD, Gallagher MJ, et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema [J]. Ophthalmology, 2009, 116: 902- 913.
  • 8Chan WC, Tsai SH, Wu AC, et al. Current treatments of diabetic macular edema [J]. Int J Gerontology, 2011,5: 183- 188.
  • 9Browning DJ, Glassman AR, Aiello I.P, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema [J]. Ophthalmology, 2007,114 : 525-536.
  • 10Chung H, Park B, Shin HJ, et al. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema [J]. Ophthalmology, 2012,119 : 1056-1065.

二级参考文献36

  • 1俞素勤,张晰,许迅.微脉冲激光技术在眼科的应用[J].中国实用眼科杂志,2004,22(7):490-492. 被引量:2
  • 2Salem W,Fraser-Bell S,Gillies M. Clinical development of new treatments for diabetic macular oedema[J].Clinical and Experimental Optometry,2012.297-305.
  • 3Stef(a)nsson E. The therapeutic effects of retinal laser treatment and vitrectomy:a theory based on oxygen and vascular physiology[J].Acta Ophthalmologica Scandinavica,2001.435-440.
  • 4Patz A,Rice TA,Murphy RP. Photocoagulation for diabetic macular edema:Early Treatment Diabetic Retinopathy Study report number 1[J].Archives of Ophthalmology,1985.1796-1806.
  • 5Gupta V,Gupta A,Kaur R. Efficacy of various laser wavelengths in the treatment of clinically significant macular edema in diabetics[J].Ophthalmic Surgery & Lasers,2001.397-405.
  • 6Fong DS,Strauber SF,Aiello LP. Writing committee for the diabetic retinopathy clinical research network:comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema[J].Archives of Ophthalmology,2007.469-480.
  • 7Laursen ML,Moeller F,Sander B. Subthresnold micropulse diode laser treatment in diabetic macular oedema[J].British Journal of Ophthalmology,2004.1173-1179.
  • 8Nasrallah FP,Jalkh AE,Van Coppenolle F. The role of the vitreous in diabetic macular edema[J].Ophthalmology,1988.1335-1339.
  • 9Lewis H,Abrams GW,Blumenkranz MS. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction[J].Ophthalmology,1992.753-759.
  • 10Diabetic Retinopathy Clinical Research Network Writing Committee,Haller JA,Qin H. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction[J].Ophthalmology,2010.1087-1093.

共引文献18

同被引文献243

  • 1赵欣,张仲臣.光学相干断层扫描在糖尿病合并白内障超声乳化术后黄斑区厚度变化的研究现状[J].中华临床医师杂志(电子版),2012,6(19):5953-5955. 被引量:7
  • 2李岩,齐朋承,刘佳.中老年糖尿病眼底病变患者白内障术后的黄斑水肿和视力[J].中国老年学杂志,2014,34(1):1-3. 被引量:26
  • 3夏晓波,蒋剑,刘丹.白内障的手术治疗[J].现代养生,2013,0(6):35-36. 被引量:1
  • 4孙倩,邹海东,缪浴宇,郑高欣.糖尿病患者白内障术后黄斑区视网膜厚度和血-房水屏障改变[J].眼科新进展,2006,26(8):599-601. 被引量:23
  • 5Funatsu H, Noma H, Mimura T, et al. Association of vitreous inflammatory factors with diabetic maeular edema [ J ]. Ophthalmology ,2009,116:73-79.
  • 6Gillies M, Intri MC, Sutter FK, et al. Real trlameinolone for diabetic maeular result sofa refractory edema: two lear clinical double-masked placebo-controlled randomized trial [ J ]. Ophthalmology ,2006,113 : 1533-1538.
  • 7Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales [ J ]. Ophthalmology, 2003, 110: 1677-1682.
  • 8Mclntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion : an evidence-based systematic review [ J ]. Ophthalmology ,2010,117 : 1113-1123.
  • 9Pearson PA, Comstock TL, Ip Met al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year muhicenter, randomized, controlled clinical trial [ J ]. Ophthalmology ,2011,118 : 1580-1587.
  • 10Rinaldi M, Chiosi F, dell'Omo R, et al. Intravitreal pegaptanib sodium ( Macugen ) for treatment of diabetic macular oedema: a morphologic and functional study [ J ], Br J Clin Pharmacol,2012, 74:940-946.

引证文献24

二级引证文献155

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部